Subscribe Best Stocks for Vaccine and Infectious Diseases ( Covid/Monkeypox ) Skip to main content


How the Saint Lucia Citizenship By Investment Program Can Benefit Crypto Investors Seeking a Tax Haven

  Photo by yousef alfuhigi on Unsplash Cryptocurrency investors are always on the lookout for tax-efficient solutions to minimize their tax liabilities. One option that is gaining popularity among investors is the Saint Lucia Citizenship By Investment Program. In this article, we'll explore how this program can benefit cryptocurrency investors looking for a tax haven country. Saint Lucia is a sovereign island country located in the Caribbean Sea. Its Citizenship By Investment Program (CIP) was established in 2015, allowing investors to obtain a second passport by making a qualifying investment in the country. Saint Lucia's CIP has become a popular choice for high-net-worth individuals and entrepreneurs seeking a safe haven to protect their assets and minimize their tax liabilities. Saint Lucia's second passport permits travel to 145+ global countries visa-free, including the United Kingdom, Singapore, Hong Kong, as well as the European Union countries. The Saint Lucia pass

Best Stocks for Vaccine and Infectious Diseases ( Covid/Monkeypox )

4 Monkeypox/Covid Stocks to Keep an Eye On Right Now
Cases of monkeypox are increasing, but these companies may be able to combat the disease

$SIGA SIGA Technologies Inc
SIGA Technologies Inc is a commercial-stage pharmaceutical company specializing in health security. TPOXX, an orally administered antiviral drug for the treatment of human smallpox disease caused by the variola virus, is the company's lead product. Its products are intended to treat orthopoxvirus infections such as smallpox.

$BVNRY Bavarian Nordic 
Bavarian Nordic A/S is a biotechnology company that specializes in the development, manufacturing, and commercialization of cancer immunotherapies and infectious disease vaccines. The company focuses specifically on diseases with high unmet medical needs. Bavarian generates revenue through government R&D and supply contracts, as well as commercial partnerships. The Netherlands generates the vast majority of the company's revenue, followed by the United States, Canada, and other geographic markets.

$CMRX Chimerix Incorporated
Chimerix Inc. is a biopharmaceutical firm based in the United States that specializes in medical research, development, and commercialization. Its product portfolio includes acute myeloid leukemia (AML) treatment and antiviral treatment for smallpox. Revenue is generated through license agreements and a federal contract with the United States Biomedical Advanced Research and Development Authority (BARDA) for drug research and advanced development to treat a variety of human diseases. The company only has one business segment, which is pharmaceuticals.

 $VAXX Vaxxinity Inc.
Vaxxinity Inc develops and commercializes prophylactic and therapeutic vaccines to combat chronic disorders and infectious diseases with large patient populations and unmet medical needs. Its pipeline is primarily comprised of five programs focused on chronic disease, specifically neurodegenerative disorders, as well as other neurology and cardiovascular indications.

More Articles Below